MarketPeel
Insider Trading Intelligence
SO

Stephanie Okey

PTCT
DIRECTOR · PTC THERAPEUTICS, INC. · CIK 0001742616
FILING MIX · LIFETIME67%/33%
BUYS
29
SELLS
14
TOTAL VALUE
$3.97M
COMPANIES
2
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
31,730
AVG SELL PX
$53.60
TRADE KIND
SHOWING 43 / 43
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 13 pending
Forward-return performance of every backtestable P/S trade by Stephanie Okey, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+55.56%-0.40%-0.02%-0.37%-0.68%
14d9+33.33%+0.52%-0.96%+1.48%+1.08%
30d9+33.33%-0.69%-1.32%+0.64%+2.94%
60d9+55.56%-0.99%+3.09%-4.08%-1.98%
90d9+85.71%-7.24%+4.64%-14.11%-13.06%
180d9(4 pending)+40.00%-3.32%+9.38%-12.70%-7.56%
1y9(4 pending)+60.00%-6.99%+12.79%-19.78%-33.08%
2y9(5 pending)+75.00%-25.37%+17.38%-42.74%-50.59%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PTCT · 22,000 shares · as of Mar 10, 2026
05,50011,00016,50022,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 29 buys / 14 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
9,7309,730Jun 18, 2026Jun 22, 2026View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,92512,325Jun 18, 2026Jun 22, 2026View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,292$35.62$224.1K7,008Jun 17, 2026Jun 18, 2026View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
608$36.22$22.0K6,400Jun 17, 2026Jun 18, 2026View →
PTCT
PTC THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
14,000$70.00$980.0K8,000Mar 10, 2026Mar 12, 2026View →
PTCT
PTC THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,167$70.00$81.7K8,000Mar 10, 2026Mar 12, 2026View →
PTCT
PTC THERAPEUTICS, INC.
SALE
1,1670Mar 10, 2026Mar 12, 2026View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASE
1,167$33.63$39.2K9,167Mar 10, 2026Mar 12, 2026View →
PTCT
PTC THERAPEUTICS, INC.
SALE
14,0000Mar 10, 2026Mar 12, 2026View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASE
14,000$33.63$470.8K22,000Mar 10, 2026Mar 12, 2026View →
PTCT
PTC THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,333$63.38$401.4K8,000Mar 5, 2026Mar 9, 2026View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,000$39.67$119.0K13,300Mar 3, 2026Mar 4, 2026View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,00012,000Jan 2, 2026Jan 6, 2026View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,4753,475Jan 2, 2026Jan 6, 2026View →
PTCT
PTC THERAPEUTICS, INC.
SALEGRANT
Gift
8678,000Nov 20, 2025Nov 21, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,90016,300Jun 11, 2025Jun 13, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,35010,350Jun 11, 2025Jun 13, 2025View →
PTCT
PTC THERAPEUTICS, INC.
SALE
5,000$54.00$270.0K8,867Mar 13, 2025Mar 17, 2025View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,8008,800Jan 3, 2025Jan 7, 2025View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,00013,867Jan 3, 2025Jan 7, 2025View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,50012,500Jun 7, 2024Jun 11, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,4009,400Jun 7, 2024Jun 11, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
17,500$46.38$811.6K6,000Mar 28, 2024Apr 2, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
17,500$18.29$320.1K23,500Mar 28, 2024Apr 2, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
17,5000Mar 28, 2024Apr 2, 2024View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Feb 15, 2024Feb 16, 2024View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,0009,867Feb 15, 2024Feb 16, 2024View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,0006,000Jun 16, 2023Jun 21, 2023View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
17,50017,500Jun 16, 2023Jun 21, 2023View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 5, 2023Jan 9, 2023View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,0005,867Jan 5, 2023Jan 9, 2023View →
PTCT
PTC THERAPEUTICS, INC.
SALE
2,296$51.62$118.5K1,867Aug 9, 2022Aug 11, 2022View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
17,50017,500Jun 17, 2022Jun 21, 2022View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,2004,163Jan 7, 2022Jan 11, 2022View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,00012,000Jan 7, 2022Jan 11, 2022View →
PTCT
PTC THERAPEUTICS, INC.
SALE
1,650$40.06$66.1K963Aug 13, 2021Aug 17, 2021View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
17,50017,500Jun 22, 2021Jun 23, 2021View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,6502,613Jan 6, 2021Jan 8, 2021View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 6, 2021Jan 8, 2021View →
PTCT
PTC THERAPEUTICS, INC.
SALE
687$62.52$43.0K963Dec 8, 2020Dec 10, 2020View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,50012,500Jun 19, 2020Jun 22, 2020View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,6501,650Jan 29, 2020Jan 31, 2020View →
PTCT
PTC THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 29, 2020Jan 31, 2020View →
Other insiders · PTCT
Loading peer insiders…
About this filer
CIK 0001742616
ROLE
Director
PRIMARY
PTCT
COMPANIES
2
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001742616DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback